Table 1 Demographic data and clinical chemistry test results for the enrolled pregnant women and the newborns in the present study

Age (year)

29.42 ± 2.17

30.09 ± 3.08

0.26

BMI of the pregnant women (Kg/m²)

26.29 ± 2.74

26.27 ± 3.48

0.76

Fetus number (singleton/multiple pregnancies)

6/5

9/2

0.18 (χ² = 2.93)^*

gestational weeks of delivery

38.85 ± 0.95

38.91 ± 0.83

0.69

TSH (μIU/ml)

2.20 ± 0.37

2.28 ± 0.32

0.91

FT3 (pmol/L)

4.78 ± 0.47

4.85 ± 0.48

0.48

FT4 (pmol/L)

15.59 ± 2.10

16.47 ± 2.57

0.30

anti-TPO antibodies (IU/ml)

15.11 ± 4.16

273.70 ± 168.50

0.00047

FBG in the 11th gestational week (mmol/L)

4.65 ± 0.19

5.18 ± 0.69

0.06

FBG at delivery (mmol/L)

4.44 ± 0.32

4.91 ± 0.60

0.09

Gender of the newborns (Male/Female)

5/6

6/5

0.39 (χ² = 0.78)^#

Birthweight of the newborns (Kg) (Q1, Q2, Q3)^a

3.32 ± 0.35

(3.17, 3.38, 3.51)

3.14 ± 0.21

(3.02, 3.09, 3.27)

0.52